Share |

Cambridge

How TechBio is speeding up clinical trials and cutting through red tape

April 13, 2023

Hanadi Jabado, managing partner at innovation investment fund Sana Capital, talks about how independent thinking and positive change is making medical advancement faster and more effective.

The traditional route from innovative ideation to hitting the market is littered with bottlenecks and bureaucracy. However, Hanadi Jabado, managing partner at innovation investment fund Sana Capital, is extolling the virtues of TechBio’s cost-and-time-cutting benefits.

Here, she talks about how independent thinking and positive change is making medical advancement faster and more effective.

Tech Bio: Why data-driven technologies are the way forward

February 16, 2023

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes. Here, she talks to Campden FB about starting the medical and cost-efficient benefits of Tech Bio and the rising importance of ‘data donation’…

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes.

A managing partner at innovation investment fund Sana Capital, Hanadi is a passionate advocate for global information sharing and firmly believes the time is now for private investment in early-stage companies that are set to positively shape the future of healthcare.

Venture capital: Ensuring meaningful impact and return on investment

June 23, 2022

Strategic leader Hanadi Jabado talks about how her impactful investment strategy can do good and do well.

Hanadi Jabado is a passionate advocate for entrepreneurship and innovation. When she relocated to the Cambridge ecosystem, her exposure to the best of tech in Europe allowed her to develop a skill for understanding and explaining the needs of early-stage ventures. With successful investments across diverse sectors, she has since seen many startups go on to great things.

Families invest in world-leading deep technology with Amadeus Capital Partners

February 4, 2021

Amadeus Capital Partners brings together global investors and revolutionary innovations in deep technology and is building on its legacy of partnerships with family offices in 2021.

Amadeus Capital Partners brings together global investors and revolutionary innovations in deep technology and is building on its legacy of partnerships with family offices in 2021.

Next generation to take charge at UK group

July 12, 2011

Sir Michael Marshall, chief executive of family-owned Marshall Group of Companies, will step down and make way for his son Robert, in a move by the family to divide responsibilities with the next generation.

In a statement on 12 July, the Cambridge, UK-based motor retail, aerospace and vehicle engineering company said that 79-year-old Michael will remain chairman of the group, while his son will become chief executive. The change will be effective from January next year.